Therefore, PA penetrates the blood‐brain barrier, restores PA metabolism disorder in the brain, inhibits JNK phosphorylation, and upregulates BDNF expression to alleviate AD‐induced cognitive damage and pathological progression. Here, MAPK8 is linked to Alzheimer disease.